Alkoholische Hepatitis

Schlüsselwörter

Hepatitis - Alkohol - Prognose-Scores - N-Acetylcystein - Glukokortikoide

Keywords

Hepatitis - alcohol - prognostic scores - N-acetylcyteine

• Literatur

• 1 Affo S, Dominguez M, Lozano JJ et al. Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis. Gut 2013; 62: 452-460
• 2 European Association for the Study of Liver. EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol 2012; 57: 399-420
• 3 Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011; 141: 1572-1585
• 4 Louvet A, Naveau S, Abdelnour M et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 2007; 45: 1348-1354
• 5 Mathurin P, Moreno C, Samuel D et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med 2011; 365: 1790-1800
• 6 Mathurin P, O'Grady J, Carithers RL et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut 2011; 60: 255-260
• 7 Mueller S, Millonig G, Sarovska L et al. Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J Gastroenterol 2010; 16: 966-972
• 8 Naveau S, Chollet-Martin S, Dharancy S et al. A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology 2004; 39: 1390-1397
• 9 Nguyen-Khac E, Thevenot T, Piquet MA et al. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med 2011; 365: 1781-1789
• 10 O'Shea RS, Dasarathy S, McCullough AJ. Practical Guideline Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease. Hepatology 2010; 51: 307-328
• 11 Parker R, Armstrong MJ, Corbett C et al. Pentoxifylline for the treatment of severe alcoholic hepatitis. Aliment Pharmacol Ther 2013; 37: 845-854
• 12 Plauth M, Cabre E, Riggio O et al. ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr 2006; 25: 285-294
• 13 Rivera CA, Adegboyega P, van Rooijen N et al. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol 2007; 47: 571-579
• 14 Stickel F, Hoehn B, Schuppan D et al. Nutritional therapy in alcoholic liver disease. Aliment Pharmacol Ther 2003; 18: 357-373
• 15 Stickel F, Seitz HK. Update on the management of alcoholic steatohepatitis. J Gastrointestin Liver Dis 2013; 22: 189-197